IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Recip Buys AstraZeneca Plant

6:21 AM MDT | August 7, 2007 | Chemical Week Editorial Staff

Recip Pharma (Haninge, Sweden), a contract manufacturer, says it has completed the acquisition of AstraZeneca’s sterile products manufacturing plant near Monts, France. Financial terms were not disclosed. Recip Pharma will operate the plant to manufacture and fill vials with a range of AstraZeneca’s anaesthetic products. The acquisition is Recip Pharma’s first outside of Sweden. AstraZeneca says it decided to sell the plant because of growing competition from generic anaesthetic manufacturers. All of AstraZeneca’s staff at the site has...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa